相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Feature selection strategies for drug sensitivity prediction
Krzysztof Koras et al.
Scientific Reports (2020)
The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells
Sivan Izraely et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
Lian Lian et al.
BMC CANCER (2019)
VEGFR2 activation mediates the pro-angiogenic activity of BMP4
Sara Rezzola et al.
ANGIOGENESIS (2019)
The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
Gledson L. Picharski et al.
CANCERS (2019)
The Pfam protein families database in 2019
Sara El-Gebali et al.
NUCLEIC ACIDS RESEARCH (2019)
Overview of current systemic management of EGFR-mutant NSCLC
W. -H. Hsu et al.
ANNALS OF ONCOLOGY (2018)
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies
Rodrigo A. Toledo et al.
CLINICAL CANCER RESEARCH (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Advances in studies of tyrosine kinase inhibitors and their acquired resistance
Qinlian Jiao et al.
MOLECULAR CANCER (2018)
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas
Alberto Picca et al.
NEUROLOGY (2018)
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
Matthew Dankner et al.
ONCOGENE (2018)
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations
Ting-Hui Wu et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Targeting TRK family proteins in cancer
Yekaterina B. Khotskaya et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma
Todd C. Knepper et al.
JAMA DERMATOLOGY (2017)
Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
Runjun D. Kumar et al.
SCIENTIFIC REPORTS (2017)
Multi-physics interactions drive VEGFR2 relocation on endothelial cells
Valentina Damioli et al.
SCIENTIFIC REPORTS (2017)
MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer
Nicholas Paul Gauthier et al.
NUCLEIC ACIDS RESEARCH (2016)
LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer
Giorgio E. M. Melloni et al.
BMC BIOINFORMATICS (2016)
Pan-Cancer Analysis of Mutation Hotspots in Protein Domains
Martin L. Miller et al.
CELL SYSTEMS (2015)
The regulation of MMP targeting to invadopodia during cancer metastasis
Abitha Jacob et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice
Emily Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Signal Transduction by Vascular Endothelial Growth Factor Receptors
Sina Koch et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
Karoline V. Gleixner et al.
BLOOD (2011)
Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer
Jenn-Yu Wu et al.
CLINICAL CANCER RESEARCH (2011)
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
Eric W. Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
Ryan J. Mattison et al.
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation
Hitoshi Kiyoi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
IL-12 regulates an endothelial cell-lymphocyte network: Effect on metalloproteinase-9 production
S Mitola et al.
JOURNAL OF IMMUNOLOGY (2003)
Studying protein dynamics in living cells
J Lippincott-Schwartz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice
T Iwata et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
